tiprankstipranks
Advertisement
Advertisement

DWTX Stock Latest News

Dogwood management to meet with Maxim
The FlyDogwood management to meet with Maxim
5d ago
DWTX
Dogwood sees cash runway into 4Q26
PremiumThe Fly
Dogwood sees cash runway into 4Q26
6d ago
DWTX
Dogwood reports Q4 EPS (26c) vs. ($6.29) last year
PremiumThe Fly
Dogwood reports Q4 EPS (26c) vs. ($6.29) last year
6d ago
DWTX
Dogwood Therapeutics Shareholders Approve Warrant Exercise Proposal
PremiumCompany Announcements
Dogwood Therapeutics Shareholders Approve Warrant Exercise Proposal
12d ago
8K
DWTX
Dogwood Therapeutics: Strengthened Capital Structure, Advancing Pain Pipeline, and Extended IP Support a Buy-Rated Risk-Reward Profile
PremiumRatings
Dogwood Therapeutics: Strengthened Capital Structure, Advancing Pain Pipeline, and Extended IP Support a Buy-Rated Risk-Reward Profile
2M ago
DWTX
Dogwood announces 50% enrollment in ongoing Halneuron Phase 2b trial
PremiumThe FlyDogwood announces 50% enrollment in ongoing Halneuron Phase 2b trial
2M ago
DWTX
Dogwood Therapeutics outlines 2026 plans for pain pipeline
Premium
Company Announcements
Dogwood Therapeutics outlines 2026 plans for pain pipeline
2M ago
8K
DWTX
Closing Bell Movers: JB Hunt down over 4% after soft Q1 sales
Premium
The Fly
Closing Bell Movers: JB Hunt down over 4% after soft Q1 sales
2M ago
C
BK
Dogwood files to sell 6.43M shares of common stock for holders
PremiumThe Fly
Dogwood files to sell 6.43M shares of common stock for holders
2M ago
DWTX
Dogwood Therapeutics Raises Capital via Registered Direct Financing
PremiumCompany Announcements
Dogwood Therapeutics Raises Capital via Registered Direct Financing
2M ago
8K
DWTX
Dogwood announces financing of up to $26.8M
PremiumThe Fly
Dogwood announces financing of up to $26.8M
2M ago
DWTX
Dogwood announces interim Phase 2b trial results on Halneuron
PremiumThe Fly
Dogwood announces interim Phase 2b trial results on Halneuron
3M ago
DWTX
Dogwood files for IP protection for synthetic Halneuron
PremiumThe FlyDogwood files for IP protection for synthetic Halneuron
4M ago
DWTX
Dogwood Therapeutics Approves Equity Plan Amid Business Merger
Premium
Company Announcements
Dogwood Therapeutics Approves Equity Plan Amid Business Merger
4M ago
8K
DWTX
Dogwood enrolls first 100 patients in Halneuron Phase 2b trial
Premium
The Fly
Dogwood enrolls first 100 patients in Halneuron Phase 2b trial
4M ago
DWTX
Strategic Acquisitions and Promising Trials Bolster Buy Rating for Dogwood Therapeutics
PremiumRatings
Strategic Acquisitions and Promising Trials Bolster Buy Rating for Dogwood Therapeutics
4M ago
DWTX
Dogwood Therapeutics Advances Pain Treatment Pipeline
PremiumCompany Announcements
Dogwood Therapeutics Advances Pain Treatment Pipeline
5M ago
DWTX
Dogwood reports Q3 EPS ($8.20) vs ($2.05) last year
PremiumThe Fly
Dogwood reports Q3 EPS ($8.20) vs ($2.05) last year
5M ago
DWTX
Dogwood Therapeutics Announces Business Combination Plans
PremiumCompany Announcements
Dogwood Therapeutics Announces Business Combination Plans
6M ago
8K
DWTX
Dogwood to present on Halneuron pain research program
PremiumThe FlyDogwood to present on Halneuron pain research program
6M ago
DWTX
Dogwood files to sell 28.04M shares of common stock for holders
Premium
The Fly
Dogwood files to sell 28.04M shares of common stock for holders
6M ago
DWTX
Strategic Advancements and Growth Potential: Dogwood Therapeutics’ Acquisition of SP16
Premium
Ratings
Strategic Advancements and Growth Potential: Dogwood Therapeutics’ Acquisition of SP16
6M ago
DWTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >